OKT3 prophylaxis in renal grafts with prolonged cold ischemia times: Association with improvement in long-term survival
- 1 March 1996
- journal article
- Published by Elsevier in Kidney International
- Vol. 49 (3) , 768-772
- https://doi.org/10.1038/ki.1996.106
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- A RANDOMIZED CLINICAL TRIAL OF INDUCTION THERAPY WITH OKT3 IN KIDNEY TRANSPLANTATIONTransplantation, 1993
- THE LONG-TERM EFFECTS OF PROPHYLACTIC OKT3 MONOCLONAL ANTIBODY IN CADAVER KIDNEY TRANSPLANTATION—A SINGLE-CENTER, PROSPECTIVE, RANDOMIZED STUDYTransplantation, 1992
- ANALYSES OF THE UNOS SCIENTIFIC RENAL TRANSPLANT REGISTRY AT THREE YEARS—EARLY EVENTS AFFECTING TRANSPLANT SUCCESS1–3Transplantation, 1992
- OKT3 in organ transplantationTransplantation Reviews, 1991
- A COMPARISON OF THE EFFECTS OF CYCLOSPORINE VERSUS ANTILYMPHOCYTE GLOBULIN ON DELAYED GRAFT FUNCTION IN CADAVER RENAL TRANSPLANT RECIPIENTSTransplantation, 1989
- DETRIMENTAL EFFECT OF CYCLOSPORINE ON INITIAL FUNCTION OF CADAVER RENAL ALLOGRAFTS FOLLOWING EXTENDED PRESERVATION Results of a randomized Prospective StudyTransplantation, 1986
- A Randomized Clinical Trial of OKT3 Monoclonal Antibody for Acute Rejection of Cadaveric Renal TransplantsNew England Journal of Medicine, 1985
- The Human T-Cell ReceptorNew England Journal of Medicine, 1985
- A Randomized Clinical Trial of Cyclosporine in Cadaveric Renal TransplantationNew England Journal of Medicine, 1983
- Monoclonal Antibodies Defining Distinctive Human T Cell Surface AntigensScience, 1979